
NRx Pharmaceuticals (NASDAQ: NRXP) to Present at Wall Street Conference on May 21
NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, announced that Founder and CEO Dr. Jonathan Javitt will deliver a company update at the Wall Street Conference on May 21, 2025, in Palm Beach, Florida. NRx is one of six companies invited to present at the high-profile event, which is expected to draw more than 1,000 attendees representing over $1 trillion in investment capital.
The presentation will highlight the company's progress toward FDA approval of NRX-100, a preservative-free intravenous ketamine formulation, as well as its strategic acquisition plans for HOPE clinics focused on treating suicidal depression, PTSD, and related conditions.
To view the full press release, visit https://ibn.fm/eYj6T
About NRx Pharmaceuticals, Inc.
NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain, and PTSD. The Company is developing NRX-101, an FDA-designated investigational Breakthrough Therapy for suicidal treatment-resistant bipolar depression and chronic pain. NRx plans to file an NDA for Accelerated Approval for NRX-101 in patients with bipolar depression and suicidality or akathisia. NRX-101 additionally has potential to act as a non-opioid treatment for chronic pain, as well as a treatment for complicated UTI.
NRx has recently initiated a New Drug Application filing for NRX-100 (IV ketamine) for the treatment of suicidal depression, based on results of well-controlled clinical trials conducted under the auspices of the US National Institutes of Health and newly obtained data from French health authorities, licensed under a data sharing agreement. NRx was awarded Fast Track Designation for development of ketamine (NRX-100) by the US FDA as part of a protocol to treat patients with acute suicidality.
For more information, please visit https://www.nrxpharma.com/
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer
Corporate Communications
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

CBC
18 minutes ago
- CBC
Doctors Manitoba cheers changes to help U.S. physicians relocate to province
Regulatory changes intended to make it easier for U.S.-based physicians to relocate and practice in Manitoba are being loudly applauded by an advocacy group in the province. "We're really excited about it. Manitoba has one of the worst doctor shortages in the country, and as practising physicians, we see the consequences of this every day," said Doctors Manitoba president Nichelle Desilets. The College of Physicians and Surgeons of Manitoba and the provincial government recently took steps to streamline the process for qualified physicians from the United States to be granted a full licence to practice in the province, provided they meet certain requirements. They have to first complete an accredited residency program, have certification from the American Board of Medical Specialists and have a licence from a U.S. state medical board. "The training that American physicians undergo is very similar to a Canadian physician. I would even say nearly identical," said Desilets, who practises in Neepawa. "There is much more in common than there is different." Processes the government and college have agreed to remove include things like requiring supervisors and formal assessments, and restrictions on where a new doctor can practise — which can all be costly and time-consuming. Doctors Manitoba advocated for such changes more than a year ago, Desilets said. "Manitoba has been behind in making these changes, so it's really great to see that we're catching up on that," Desilets said. B.C., Saskatchewan, New Brunswick, Nova Scotia and P.E.I. have already simplified the process, she said. It's also important to underscore the fact that none of the changes will compromise the quality of patient care, she said. "The public should still be reassured that there is still a rigorous process making sure that every doctor that practises in Manitoba is qualified to do so and has been vetted by our college." The province has also followed the lead of Doctors Manitoba by launching recruitment campaigns in the U.S. The provincial government is targeting health-care workers in the nearby states of Michigan, Minnesota, North Dakota and South Dakota, touting Manitoba's strengths and priorities, including safe and inclusive communities, good schools, strong social supports and comparable affordability with a high quality of life. Doctors Manitoba had ramped up its own recruitment efforts late last year with a similar message in an effort to appeal to physicians in search of stability and respect after Donald Trump was elected U.S. president. "We have the privilege of working in an environment where the government doesn't generally get in between us and our patients, so that was the kind of the selling point that we brought," Desilets said. "We're grateful to see that our public advocacy efforts were able to influence government stakeholders and our own regulatory college to take a look at all of the requirements and to kind of take our lead." She couldn't say, though, if the efforts have prompted anyone to relocate north of the border. "As a front-line working doctor, I wouldn't be privy to that knowledge, but we do know that our office has had people reach out to inquire about the process and what the work environment looks like," Desilets said. "Despite the flaws in our health-care system, and I acknowledge that there are many of them, I am safe when I go to work, I know that the government is going to pay me for the services that I provide to patients, and I know that I have an organization that backs me and my colleagues up when we go to work every day." Doctors Manitoba will continue to promote those benefits through its own recruitment efforts in news media interviews, advertisements, and the website ManitobaMD.com. While the push to open the door more to American doctors is welcome, it's only one aspect of addressing the shortage, Desilets said. The barriers between provinces need to be dealt with, as well. "Even though people expect health care to be nationally available to them, it's still administered on a provincial level. So this is a barrier to recruiting physicians to Manitoba, no matter where you're coming from," she said. "The fact that we don't have enough doctors to serve our population is a multi-pronged challenge. There's not one golden answer … and we're going to continue to advocate. We need more doctors, we need more specialists."


CTV News
20 minutes ago
- CTV News
‘Inevitably going to implode': Here's what experts think about Trump and Musk's relationship as it unravels online
Psychologist Simon Sherry shares what he thinks may be behind public fallouts in the wake of Trump and Musk's online fight. It may be the most high-profile breakup between two of the most powerful and richest men in the world. Donald Trump and Elon Musk, who not too long ago was a strong ally and adviser to the U.S. president, captured the world's attention this week with their war of words on social media, including X, which Musk owns. What could be happening with the alliance between two of the world's most influential men, or what could similar feuds mean? reached out to a wide variety of experts, from a psychologist to Trump's biographer, asking what they think. Simon Sherry, a registered psychologist, said he couldn't speak directly about Trump or Musk since he has not assessed or diagnosed them. However, he said he could speak of individuals who may have certain personality traits and relationship styles that could lead to a similar public fallout. Sherry says people who exhibit narcissistic qualities generally 'don't play nicely' with each other. 'Speaking in general terms, when two narcissistic individuals interact, it often becomes a struggle for dominance,' Sherry, a professor from the department of psychology and neuroscience at Dalhousie University in Halifax, said in a video interview with on Friday. 'So if you've got traits like grandiosity and entitlement, you have a great need for admiration.' 'So if you've traits like grandiosity and entitlement, you have a great need for admiration.' These types of individuals may also be 'low on empathy' and 'cold' during interactions, he adds. 'And if you have that cold and unempathetic style, it's more likely that you're going to escalate conflict, as opposed to move toward repairing a relationship or any sort of a reconciliation.' Bree McEwan, a communication professor at the University of Toronto Mississauga, told in a video interview Friday that the public unravelling between Trump and Musk raises questions. 'This is perhaps an unusual moment where we're having power players in the U.S. government air out all of their beef in online settings,' said McEwan, who specializes in social media's role in personal communication and public discourse. 'It does allow for a lot of conversation and chatter to occur around their discussion, but it also brings up the question of how much of this is a performance, who's that performance for, and how much of this is sort of serious business of these major players,' McEwan added. The high-profile feud also has significant consequences, she adds. 'From a responsibility perspective, when you are two major players whose every action has a huge influence on world markets, there's a point here where maybe you should be picking up the phone and talking to each other, maybe have a conversation in the Oval Office,' she said. Breakup was 'inevitable': Trump biographer Marc Fisher, co-author of the 2016 book 'Trump Revealed: An American Journey of Ambition, Ego, Money, and Power,' called the duo's breakup 'inevitable.' 'This is a case of two wealthy and narcissistic billionaires, who are very accustomed to having the spotlight entirely to themselves and find that, when someone challenges them, they tend to push back pretty hard,' Fisher said in a video interview with on Friday. He added that the fallout 'makes perfect sense,' with Musk moving on as a top White House adviser. 'He had endangered his own businesses by devoting himself entirely to his time in Washington, and so he's now abandoned Trump and Trump doesn't like that,' he said. 'He doesn't like when people separate from him or critique him in any way, and so we have this battle of the wits and battle of the wills going that very much reflects the personalities of both men.' Both Musk and Trump are prone to 'overreactions' and 'emotional reactions,' Fisher added. 'Both of them see this kind of dispute as something that ought to play out in public, because that gives them even more attention, and attention is really the currency by which they measure their own success,' he said. Fisher adds that the public fight positions Trump as standing up to a billionaire, while Musk may be trying to prove to his stockholders that he's paying attention to his business. 'Neither of them has much to lose here,' he said. 'A marriage of convenience' Fisher doesn't believe Trump and Musk had a genuine connection. 'It was a marriage of convenience, really more of an accident than anything else, doomed from the start,' Fisher said. 'It's the kind of relationship that was perhaps mutually beneficial for a short time but was inevitably going to implode.' For Trump, Musk provided 'extraordinary energy' to allow Trump and his officials to show they were 'really tearing the federal government apart,' Fisher said, noting Trump seems to have less energy now than during his first administration. 'For Musk, this was an opportunity to push forward his business interests, get in close with the president who had a significant sway over whether large government contracts, which are at the heart of Musk's operations, would come his way and stay with his companies,' Fisher said. 'And so this was really, something that seemed mutually beneficial for a time.' 'Kerosene being thrown on this fire' Jeffrey Dvorkin, a media observer and former director of the journalism program at University of Toronto, had some ideas on what may be happening with the insults between the two men online. He called social media the 'kerosene being thrown on this fire.' 'I think that what we're seeing is the acting out of these unresolved issues that stem from childhood, but now have a terrible impact on the rest of us,' the senior fellow of Massey College at the University of Toronto said in a video interview with on Friday, referring to their 'very demanding' fathers. 'It is a destabilizing situation in the United States in the American government, which is never good for anybody.' Meanwhile, he said Musk is 'a disruptor.' 'He's throwing his toys around the room, hoping someone will pick up after him,' Dvorkin said. 'There may be some rationalization of what they're doing and why they're doing it, but I think deep down, we're dealing with two deeply flawed people, who have never really learned how to play well with others.' But Dvorkin sees one benefit in the feud. 'The only advantage I can see is that Canada now has a new prime minister who seems to be a grown up, the adult in the room, and he will now be able to exercise a level of control that maybe the previous prime minister was unable or unwilling to do,' he said.


Globe and Mail
36 minutes ago
- Globe and Mail
Why Dogecoin Is Plummeting Today
The price of Dogecoin (CRYPTO: DOGE) is sinking on Friday. The meme coin saw its value decline 5.3% in the last 24 hours as of 11:58 p.m. ET, but was down as much as 15.3% in that time frame. The slump comes as the S&P 500 gained 0.9% and the Nasdaq Composite gained 1.1%. Dogecoin's most prominent backer, Elon Musk, is involved in a very public spat with President Donald Trump. The tech titan appears to no longer be in the good graces of the president. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More » Musk-Trump Feud For years, Musk has been able to influence the price of Dogecoin with a tweet. His backing of Donald Trump's presidential run and subsequent place in his administration as the head of the Department of Government Efficiency (DOGE) -- so named as a not-so-subtle wink to Dogecoin -- propelled Dogecoin to heights not seen since 2021. The price more than doubled in the days following the election. Investors seemed to believe that Musk's relationship with Trump would benefit the crypto. Now, however, Musk and Trump are in the midst of a public spat, leading to Dogecoin's drop. Musk took to X to criticize Trump's flagship "Big, Beautiful Bill," calling for it to be killed off in its current form. Trump responded both on his own social media platform as well as in comments to the White House press. Dogecoin is built on hype Dogecoin is a meme coin. Its value is derived not from utility, but from "vibes." That makes it incredibly volatile and subject to wild swings in price. Its recent price appreciation was built entirely on the hype that surrounded Musk's place at Trump's side, so when that goes away, so too does the hype. I would not put my money in Dogecoin. Should you invest $1,000 in Dogecoin right now? Before you buy stock in Dogecoin, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Dogecoin wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $674,395!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $858,011!* Now, it's worth noting Stock Advisor 's total average return is997% — a market-crushing outperformance compared to172%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 2, 2025